-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Mosunetuzumab-axgb (Lunsumio™) : Oncology Times - 8 month(s) ago
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Annual Meeting - cns.org - 8 month(s) ago
2023 Annual Meeting Committee Elad I. Levy CNS President Lola B. Chambless Annual Meeting Chair Garni Barkhoudarian Scientific Program Chair Edjah K. Nduom Vice-Scientific Program Chair …
Source: www.cns.orgCategories: Latest Headlines, NeurologyTweet-
Attending #2023CNS? Don't miss the chance to learn & experience live surgeries in the Xperience Lounge! There will be 5 opportunities to watch these surgeries covering #cerebrovascular, #tumor, and #trauma. Thank you to our sponsors & join us in DC to see: https://t.co/5h6u7Q8axv https://t.co/E4rf5EUeqi
-
-
Mashup Score: 1Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes - Genome Biology - 8 month(s) ago
Background RNA profiling technologies at single-cell resolutions, including single-cell and single-nuclei RNA sequencing (scRNA-seq and snRNA-seq, scnRNA-seq for short), can help characterize the composition of tissues and reveal cells that influence key functions in both healthy and disease tissues. However, the use of these technologies is operationally challenging because of high costs and stringent sample-collection requirements. Computational deconvolution methods that infer the composition of bulk-profiled samples using scnRNA-seq-characterized cell types can broaden scnRNA-seq applications, but their effectiveness remains controversial. Results We produced the first systematic evaluation of deconvolution methods on datasets with either known or scnRNA-seq-estimated compositions. Our analyses revealed biases that are common to scnRNA-seq 10X Genomics assays and illustrated the importance of accurate and properly controlled data preprocessing and method selection and optimization.
Source: genomebiology.biomedcentral.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Annual Meeting - cns.org - 9 month(s) ago
2023 Annual Meeting Committee Elad I. Levy CNS President Lola B. Chambless Annual Meeting Chair Garni Barkhoudarian Scientific Program Chair Edjah K. Nduom Vice-Scientific Program Chair …
Source: www.cns.orgCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers are working on a #NewTechnology called Digital Spatial Profiling. By staining a #Tumor and selecting regions of interest, the technology can take these sections of tissue and do gene expression from highly targeted regions within the tumor: https://t.co/cxg7pqUeBw https://t.co/wTRH2GLCuv
-
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“We're at the beginning of the golden age of cell therapy,” said Michael Kalos, PhD. Cellular therapies can modify the cancerous #tumor and the tumor microenvironment. Rapid advances in #medicine offer hope for more effective treatments: https://t.co/ob6C4gYxHz #CancerResearch https://t.co/OeuuWErwBt
-
-
Mashup Score: 8Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer - 9 month(s) ago
Nature Biomedical Engineering – Bone-matrix mineralization induces a less proliferative phenotype in breast cancer cells, as shown in collagen-based matrices with adjustable mineralization and in…
Source: www.nature.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Pancreatic ductal #adenocarcinoma remains a challenging malignancy with a dismal prognosis of a mere 11% 5-year survival rate. Researchers found that variations in RNA processing, governed by the protein RBFOX2, drive pancreatic #tumor metastasis. https://t.co/mos5OpGmhy https://t.co/nBJ8aumNF6